Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Benjamin W Bond, Bea Duric, Edoardo Spinazzola, Giulia Trotta, Edward Chesney, Zhikun Li, Diego Quattrone, Giada Tripoli, Charlotte Gayer-Anderson, Victoria Rodriguez, Laura Ferraro, Caterina La Cascia, Ilaria Tarricone, Andrei Szöke, Celso Arango, Julio Bobes, Miquel Bernardo, Cristina Marta Del-Ben, Paulo Rossi Menezes, Jean-Paul Selten, Bart P F Rutten, Lieuwe de Haan, Simona Stilo, Franck Schürhoff, Baptiste Pignon, Tom P Freeman, Evangelos Vassos, Robin M Murray, Isabelle Austin-Zimmerman, Marta Di Fort. Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2025-01-15. PMID:39810593. |
cannabis use cessation and the risk of psychotic disorders: a case-control analysis from the first episode case-control eu-gei wp2 study: l'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: une analyse cas-témoins tirée de l'étude cas-témoins eu-gei wp2 centrée sur les premiers épisodes psychotiques. |
2025-01-15 |
2025-01-17 |
Not clear |
Benjamin W Bond, Bea Duric, Edoardo Spinazzola, Giulia Trotta, Edward Chesney, Zhikun Li, Diego Quattrone, Giada Tripoli, Charlotte Gayer-Anderson, Victoria Rodriguez, Laura Ferraro, Caterina La Cascia, Ilaria Tarricone, Andrei Szöke, Celso Arango, Julio Bobes, Miquel Bernardo, Cristina Marta Del-Ben, Paulo Rossi Menezes, Jean-Paul Selten, Bart P F Rutten, Lieuwe de Haan, Simona Stilo, Franck Schürhoff, Baptiste Pignon, Tom P Freeman, Evangelos Vassos, Robin M Murray, Isabelle Austin-Zimmerman, Marta Di Fort. Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2025-01-15. PMID:39810593. |
to establish whether the risk of psychotic disorders in cannabis users changes with time following cannabis cessation using data from the european network of national networks studying gene-environment interactions in schizophrenia (eu-gei) case-control study. |
2025-01-15 |
2025-01-17 |
Not clear |
Marta Di Forti, Benjamin W Bond, Edoardo Spinazzola, Giulia Trotta, Jodie Lynn, Richard Malkin, Naba Kamran Siddiqui, Sultan Demir, Titilayomi Opadokun, Perry B M Leung, Zhikun Li, Andrea Quattrone, Gabriella Baxter, Elizabeth Appiah-Kusi, Tom P Freeman, Hannah Walsh, Tommaso Squeri, Daria Semikina, Felicity Amberson-Jones, Isabelle Austin-Zimmerman, Tim Meynen, Diego Quattrone, Robin M Murra. A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders. BJPsych open. vol 11. issue 1. 2024-12-12. PMID:39663754. |
a proof-of-concept analysis of data from the first nhs clinic for young adults with comorbid cannabis use and psychotic disorders. |
2024-12-12 |
2024-12-14 |
Not clear |
Marta Di Forti, Benjamin W Bond, Edoardo Spinazzola, Giulia Trotta, Jodie Lynn, Richard Malkin, Naba Kamran Siddiqui, Sultan Demir, Titilayomi Opadokun, Perry B M Leung, Zhikun Li, Andrea Quattrone, Gabriella Baxter, Elizabeth Appiah-Kusi, Tom P Freeman, Hannah Walsh, Tommaso Squeri, Daria Semikina, Felicity Amberson-Jones, Isabelle Austin-Zimmerman, Tim Meynen, Diego Quattrone, Robin M Murra. A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders. BJPsych open. vol 11. issue 1. 2024-12-12. PMID:39663754. |
cannabis use severely affects the outcome of people with psychotic disorders, yet there is a lack of treatments. |
2024-12-12 |
2024-12-14 |
Not clear |
Isabelle Austin-Zimmerman, Edoardo Spinazzola, Diego Quattrone, Beatrice Wu-Choi, Giulia Trotta, Zhikun Li, Emma Johnson, Alexander L Richards, Tom P Freeman, Giada Tripoli, Charlotte Gayer-Anderson, Victoria Rodriguez, Hannah E Jongsma, Laura Ferraro, Caterina La Cascia, Sarah Tosato, Ilaria Tarricone, Domenico Berardi, Elena Bonora, Marco Seri, Giuseppe D'Andrea, Andrei Szöke, Celso Arango, Julio Bobes, Julio Sanjuán, Jose Luis Santos, Manuel Arrojo, Eva Velthorst, Miguel Bernardo, Cristina Marta Del-Ben, Paulo Rossi Menezes, Jean-Paul Selten, Peter B Jones, James B Kirkbride, Bart P F Rutten, Andrea Tortelli, Pierre-Michel Llorca, Lieuwe de Haan, Simona Stilo, Daniele La Barbera, Antonio Lasalvia, Franck Schurnhoff, Baptiste Pignon, Jim van Os, Michael Lynskey, Craig Morgan, Michael O' Donovan, Cathryn M Lewis, Pak C Sham, Robin M Murray, Evangelos Vassos, Marta Di Fort. The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies. Psychological medicine. 2024-12-05. PMID:39637925. |
the impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the eu-gei case-control and uk biobank studies. |
2024-12-05 |
2024-12-08 |
Not clear |
Chloe Burke, Tom P Freeman, Hannah Sallis, Robyn E Wootton, Annabel Burnley, Jonas Lange, Rachel Lees, Katherine Sawyer, Gemma M J Taylo. Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis. Psychological medicine. 2024-12-02. PMID:39620474. |
associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis. |
2024-12-02 |
2024-12-06 |
Not clear |
Emilie Bouquet, Emilie Jouanjus, Stéphanie Pain, Anne Batisse, Céline Eiden, Cécile Chevallie. The contribution of addictovigilance data to the French medical cannabis experimentation. Therapie. 2024-11-15. PMID:39547825. |
data from addictovigilance and international literature on the risks associated with non-medical cannabis use have helped establish exclusion criteria for patients at risk of complications when using medical cannabis (such as those with psychotic disorders, severe cardiovascular, renal, or liver conditions). |
2024-11-15 |
2024-11-18 |
Not clear |
Ovidiu Tatar, Hamzah Bakouni, Amal Abdel-Baki, Didier Jutras-Aswa. Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update. Cannabis and cannabinoid research. 2024-10-24. PMID:39446673. |
cannabis use is highly prevalent in people with psychotic disorders and is associated with adverse outcomes. |
2024-10-24 |
2024-10-28 |
Not clear |
Özge Türkoğlu, Aygün Ertuğru. The Role of Cannabis in the Development of Psychosis. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 3. 2024-09-03. PMID:39224996. |
cannabis is known to cause psychotic disorders, and the increasing use of cannabis constitutes an important health problem. |
2024-09-03 |
2024-09-05 |
Not clear |
Özge Türkoğlu, Aygün Ertuğru. The Role of Cannabis in the Development of Psychosis. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 3. 2024-09-03. PMID:39224996. |
keywords: cannabis abuse, psychotic disorders, schizophrenia, endocannabinoids, neurobiology. |
2024-09-03 |
2024-09-05 |
Not clear |
Vera Brink, Humma Andleeb, Charlotte Gayer-Anderson, Celso Arango, Manuel Arrojo, Domenico Berardi, Miquel Bernardo, Julio Bobes, Cristina Marta Del-Ben, Laura Ferraro, Lieuwe de Haan, Daniele La Barbera, Caterina La Cascia, Antonio Lasalvia, Pierre-Michel Llorca, Paolo Rossi Menezes, Baptiste Pignon, Julio Sanjuán, José Luis Santos, Jean-Paul Selten, Ilaria Tarricone, Andrea Tortelli, Giada Tripoli, Eva Velthorst, Bart P F Rutten, Jim van Os, Diego Quattrone, Robin M Murray, Peter B Jones, Craig Morgan, Marta Di Forti, Hannah E Jongsma, James B Kirkbrid. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study. Schizophrenia bulletin. 2024-05-24. PMID:38788048. |
the role of social deprivation and cannabis use in explaining variation in the incidence of psychotic disorders: findings from the eu-gei study. |
2024-05-24 |
2024-05-27 |
Not clear |
Vera Brink, Humma Andleeb, Charlotte Gayer-Anderson, Celso Arango, Manuel Arrojo, Domenico Berardi, Miquel Bernardo, Julio Bobes, Cristina Marta Del-Ben, Laura Ferraro, Lieuwe de Haan, Daniele La Barbera, Caterina La Cascia, Antonio Lasalvia, Pierre-Michel Llorca, Paolo Rossi Menezes, Baptiste Pignon, Julio Sanjuán, José Luis Santos, Jean-Paul Selten, Ilaria Tarricone, Andrea Tortelli, Giada Tripoli, Eva Velthorst, Bart P F Rutten, Jim van Os, Diego Quattrone, Robin M Murray, Peter B Jones, Craig Morgan, Marta Di Forti, Hannah E Jongsma, James B Kirkbrid. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study. Schizophrenia bulletin. 2024-05-24. PMID:38788048. |
recent findings suggest the incidence of first-episode psychotic disorders (fep) varies according to setting-level deprivation and cannabis use, but these factors have not been investigated together. |
2024-05-24 |
2024-05-27 |
Not clear |
André J McDonald, Paul Kurdyak, Jürgen Rehm, Michael Roerecke, Susan J Bond. Age-dependent association of cannabis use with risk of psychotic disorder. Psychological medicine. 2024-05-22. PMID:38775165. |
age-dependent association of cannabis use with risk of psychotic disorder. |
2024-05-22 |
2024-05-27 |
Not clear |
André J McDonald, Paul Kurdyak, Jürgen Rehm, Michael Roerecke, Susan J Bond. Age-dependent association of cannabis use with risk of psychotic disorder. Psychological medicine. 2024-05-22. PMID:38775165. |
epidemiologic research suggests that youth cannabis use is associated with psychotic disorders. |
2024-05-22 |
2024-05-27 |
Not clear |
J P Selten, M Di Forti, D Quattrone, P B Jones, H E Jongsma, C Gayer-Anderson, A Szöke, P M Llorca, C Arango, M Bernardo, J Sanjuan, J L Santos, M Arrojo, I Tarricone, D Berardi, A Lasalvia, S Tosato, C la Cascia, E Velthorst, E M A van der Ven, L de Haan, B P Rutten, J van Os, J B Kirkbride, C M Morgan, R M Murray, F Termorshuize. The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe. Psychological medicine. 2024-05-09. PMID:38721761. |
we examined whether cannabis use contributes to the increased risk of psychotic disorder for non-western minorities in europe. |
2024-05-09 |
2024-05-27 |
Not clear |
Martina Di Paolo, Antonia Calabrese, Guido Nosari, Valentina Ciappolino, Luisa Cirella, Alice Caldiroli, Enrico Capuzzi, Massimo Clerici, Massimiliano Buol. Clinical Variables and Peripheral Biomarkers Associated with Substance-Induced Psychotic Disorder: Differences Related to Alcohol, Cannabis, and Psychostimulant Abuse. Journal of personalized medicine. vol 14. issue 3. 2024-03-28. PMID:38541067. |
clinical variables and peripheral biomarkers associated with substance-induced psychotic disorder: differences related to alcohol, cannabis, and psychostimulant abuse. |
2024-03-28 |
2024-03-30 |
Not clear |
H S van der Heijden, Martijn Kikkert, Lieuwe de Haan, Menno Segeren, Simone Molman, Frederike Schirmbeck, Jentien Vermeule. The relationship between substance use and self-reported aspects of social functioning in patients with a psychotic disorder. European psychiatry : the journal of the Association of European Psychiatrists. vol 67. issue 1. 2024-03-19. PMID:38418416. |
in patients with a psychotic disorder, rates of substance use (tobacco, cannabis, and alcohol) are higher compared to the general population. |
2024-03-19 |
2024-03-21 |
Not clear |
Nicholas Fabiano, Saumil Dholakia, Lisa A S Walker, Andrew L Smit. Chronic high-dose dimenhydrinate use contributing to early multifactorial cognitive impairment. BMJ case reports. vol 17. issue 3. 2024-03-07. PMID:38453220. |
her clinical presentation was confounded by numerous other factors that could have impacted her cognition, such as a longstanding presumed learning disability, ankylosing spondylitis with adalimumab treatment, extensive cannabis use or potential development of a primary psychotic disorder. |
2024-03-07 |
2024-03-10 |
Not clear |
Cerina Dubois, Carlotta Lunghi, Dean T Eurich, Jason R B Dyck, Elaine Hyshka, John G Hanlon, Arsene Zong. Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophrenia research. vol 264. 2024-02-08. PMID:38330686. |
medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: a propensity score-matched cohort study. |
2024-02-08 |
2024-02-11 |
Not clear |
Cerina Dubois, Carlotta Lunghi, Dean T Eurich, Jason R B Dyck, Elaine Hyshka, John G Hanlon, Arsene Zong. Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophrenia research. vol 264. 2024-02-08. PMID:38330686. |
despite evidence showing that recreational cannabis use is associated with a higher risk of psychotic disorders, this risk has not been well characterized for patients using medical cannabis. |
2024-02-08 |
2024-02-11 |
Not clear |